ABAlon Bergman

Alon Bergman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alon Bergman has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Income and Geographic Disparities in in‐Hospital Mortality Following Cardiovascular Procedures: Evidence From the National Inpatient Sample, 2016–2022

    by Alon Bergman, Ashwin Nathan

    Objective: To examine whether income‐ and geography‐related disparities in in‐hospital mortality after major cardiovascular procedures arise from differences in patient acuity, hospital characteristics, or inequities within hospitals. Study Setting and Design: This observational study analyzed national data on eight major cardiovascular procedures performed between 2016 and 2022. We used multivariable logistic regression with progressive adjustment for demographics, clinical severity (All Patient Refined Diagnosis Related Groups [APR‐DRG] risk and severity scores), and hospital characteristics. Data Sources and Analytic Sample: We analyzed secondary data from the National Inpatient Sample including 1,120,235 discharges (weighted N = 5,906,795) representing adults undergoing percutaneous coronary intervention, coronary artery bypass grafting, carotid endarterectomy/stenting, surgical valve replacement, transcatheter valve procedures, non‐carotid endarterectomy, aneurysm repair, or peripheral bypass. Patient income was proxied using ZIP code‐level median household income quartiles. Geographic location was classified as large metropolitan (≥ 1 million population), smaller metropolitan (50,000–999,999), or non‐metropolitan. Principal Findings: Lowest‐income patients presented with mean APR‐DRG risk scores 0.15–0.25 points higher than highest‐income patients. After full adjustment with hospital fixed effects, in‐hospital mortality was 0.67% points higher (95% CI: 0.08–1.26) among lowest‐income patients. Geographic patterns were complex: after adjusting for hospital characteristics, non‐metropolitan location was associated with 0.48% points higher mortality, though this was not statistically significant (95% CI: −0.01 to 0.97), and smaller metropolitan areas with 1.03% points higher mortality (95% CI: 0.30–1.76). Between‐hospital differences explained 11.6% of mortality variance. Conclusions: Socioeconomic and geographic disparities in mortality following major cardiovascular procedures persist after adjustment for clinical and hospital factors. These disparities remain, with slightly larger point estimates, in within‐hospital analyses, suggesting that hospital‐level differences alone do not account for observed inequities. Interventions should address both social determinants and intra‐hospital inequities. Multilevel interventions targeting both social determinants and within‐hospital processes may be needed.

  • Open Access

    Characterizing industry payments for FDA-approved AI medical devices

    by Alon Bergman, Tej A Patel, Kaustav P Shah

    Introduction: Artificial intelligence-enabled medical devices (AIMDs) are increasing in use, but this growth has raised concerns about inequities in access across well-resourced and under-resourced settings. Little is known about industry–clinician partnerships in the AIMD ecosystem. Methods: We examined the value, specialty distribution, market concentration, and institutional profile of payments made by industry to clinicians for Food and Drug Administration-approved AIMDs using the Open Payments Database. We linked payments to the affiliated hospital of the clinician using the Medicare Provider Data catalog. We performed a regression to explain the association of payments with hospital and county-level factors. Results: We found $59.3 million was spent on payments to 46 315 clinicians for AIMDs between 2017 and 2023, representing an increasing share of total medical device payments over time. We saw high payment concentration in technologically intensive medical specialties and among clinicians affiliated with large, urban teaching hospitals. Conclusion: Industry payments for AIMDs are increasing and concentrated among technology-intensive specialties. Payments are more likely to flow to clinicians affiliated with teaching hospitals that are larger and in non-rural areas. This may reflect or mediate increased AI utilization in these settings. Continued monitoring of payments, transparent reporting, and targeted resource support may be needed to promote equitable access to AIMDs.


  • Open Access

    Measuring hospital inpatient Procedure Access Inequality in the United States

    by Alon Bergman, Guy David, Ashwin Nathan, Jay Giri, Michael Ryan, Soumya Chikermane, Christin Thompson, Seth Clancy, Candace Gunnarsson

    Geographic disparities in access to inpatient procedures are a significant issue within the US healthcare system. This study introduces the Procedure Access Inequality (PAI) index, a standardized metric to quantify these disparities while adjusting for disease prevalence. Using data from the Healthcare Cost and Utilization Project State Inpatient Databases, we analyzed inpatient procedure data from 18 states between 2016 and 2019. The PAI index reveals notable variability in access inequality across different procedures, with minimally invasive and newer procedures exhibiting higher inequality. Key findings indicate that procedures such as skin grafts and minimally invasive gastrectomy have the highest PAI scores, while cesarean sections and percutaneous coronary interventions have the lowest. The study highlights that higher inequality is associated with greater market concentration and in particular, fewer hospitals offering these procedures. These findings emphasize the need for targeted policy interventions to address procedural access disparities to promote more equitable healthcare delivery across the United States.


  • Open Access

    Limited Access to Aortic Valve Procedures in Socioeconomically Disadvantaged Areas

    by Guy David, Alon Bergman, Candace Gunnarsson, Michael Ryan, Soumya Chikermane, Christin Thompson, Seth Clancy

    Background: To explore how differences in local socioeconomic deprivation impact access to aortic valve procedures and the treatment of aortic valve disease, in comparison to other open and minimally invasive surgical procedures. Methods and Results: Procedure volume data were obtained from the Healthcare Cost and Utilization Project from 18 states from 2016 to 2019 and merged with area deprivation index data, an index of zip code‐level socioeconomic distress. We estimate the relationship between local deprivation ranking and differences in volumes of aortic valve replacement, which include transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR), versus coronary artery bypass graft surgery and laparoscopic colectomy (LC). All regressions control for state and year fixed effects and an array of zip code‐level characteristics. TAVR procedures have increased over time across all zip codes. The rate of increase is negatively correlated with deprivation ranking, regardless of the higher share of hospitalizations per population in high deprivation areas. Distributional analysis further supports these findings, showing that lower area deprivation index areas account for a disproportionately large share of SAVR, TAVR, and LC procedures in our sample relative to their share of all hospitalizations in our sample. By comparison, the cumulative distribution of coronary artery bypass graft procedures was nearly identical to that of total hospitalizations, suggesting that this procedure is equitably distributed. Regressions show high area deprivation index areas have lower prevalence of SAVR ( β =−15.1%, [95% CI, −26.8 to −3.5]), TAVR ( β =−9.1%, [95% CI, −18.0 to −0.2]), and LC ( β =−19.9%, [95% CI, −35.4 to −4.4]), with no statistical difference in the prevalence of coronary artery bypass graft ( β =−2.5%, [95% CI, −12.7 to 7.6]), a widespread and commonly performed procedure. In the population aged ≥80 years, results show high area deprivation index areas have a lower prevalence of TAVR ( β =−11.9%, [95% CI, −18.7 to −5.2]) but not SAVR ( β =−0.8%, [95% CI, 8.1 to 6.3]), LC ( β =−3.5%, [95% CI, −13.4 to −6.4]), or coronary artery bypass graft ( β =5.2%, [95% CI, −1.1 to 1.1]). Conclusions: People living in high deprivation areas have less access to life‐saving technologies, such as SAVR, and even moreso to device‐intensive minimally invasive procedures such as TAVR and LC.


  • “I Quit”: Schedule Volatility as a Driver of Voluntary Employee Turnover

    by Alon Bergman, Guy David, Hummy Song

    Problem definition: Employers across many sectors of the economy have been fast to adopt variable work scheduling policies. The cost of this flexibility for employers is usually borne by employees, for whom unstable work schedules create several disruptions. In the context of home healthcare, we examine how employer-driven volatility in nurses’ schedules impacts their decision to voluntarily leave their job. Methodology/results: Using an instrumental variables approach, we causally identify the effect of schedule volatility on nurses’ voluntary turnover. We begin by constructing an operational measure of schedule volatility using time-stamped work log data from one of the largest home health agencies in the United States. Because this measure may be endogenous to the worker’s decision to quit, we instrument for schedule volatility using paid days off taken by other nurses in the same branch. We find that higher levels of schedule volatility substantially increase a worker’s likelihood of quitting. Specifically, a one-standard-deviation increase in schedule volatility increases the average worker’s propensity to quit on a given day by more than threefold. Translated into yearly terms, 30 days of high schedule volatility over the course of the year increases the average worker’s probability of quitting that year by 20%. Our policy simulations of counterfactual scheduling policies suggest that excess schedule volatility can explain a significant portion of voluntary turnover, and some interventions have the potential to substantially reduce workers’ daily propensity to quit. Managerial implications: This work contributes to the understanding of the extent to which employees value control over their own work schedules and are averse to volatile work schedules that are dictated by employers. Especially in the current environment where there is a growing emphasis on work-life balance and employee-driven flexibility, finding a way to support stable schedules could be important for employers to attract and retain workers. Funding: This work was supported by the National Research Service Award Postdoctoral Fellowship, the Wharton Dean's Research Fund, the Agency for Healthcare Research and Quality [T32 Grant 5T32HS26116], and the Claude Marion Endowed Faculty Scholar Award. Supplemental Material: The e-companion is available at https://doi.org/10.1287/msom.2023.1205 .


  • The Role of Schedule Volatility in Home Health Nursing Turnover

    by Alon Bergman, Hummy Song, Guy David, Joanne Spetz, Molly Candon

    Despite considerable research on nursing turnover, few studies have considered turnover among nurses working in home health care. Using novel administrative data from one of the largest home health care organizations in the United States, this study examined turnover among home health nurses, focusing on the role of schedule volatility. We estimated separation rates among full-time and part-time registered nurses and licensed practical nurses and used daily visit logs to estimate schedule volatility, which was defined as the coefficient of variation of the number of daily visits in the prior four weeks. Between 2016 and 2019, the average annual separation rate of home health nurses was over 30%, with most separations occurring voluntarily. Schedule volatility and turnover were positively associated for full-time nurses, but not for part-time nurses. These results suggest that reducing schedule volatility for full-time nurses could mitigate nursing turnover in home health care.


  • Open Access

    Disruptions in preventive care: Mammograms during the COVID‐19 pandemic

    by Hummy Song, Alon Bergman, Angela T. Chen, Dan Ellis, Guy David, Ari B. Friedman, Amelia M. Bond, Julie M. Bailey, Ronald Brooks, Aaron Smith‐McLallen

    Objective: To measure the extent to which the provision of mammograms was impacted by the COVID‐19 pandemic and surrounding guidelines.Data Sources: De‐identified summary data derived from medical claims and eligibility files were provided by Independence Blue Cross for women receiving mammograms.Study Design: We used a difference‐in‐differences approach to characterize the change in mammograms performed over time and a queueing formula to estimate the time to clear the queue of missed mammograms.Data Collection: We used data from the first 30 weeks of each year from 2018 to 2020.Principal Findings: Over the 20 weeks following March 11, 2020, the volume of screening mammograms and diagnostic mammograms fell by 58% and 38% of expected levels, on average. Lowest volumes were observed in week 15 (April 8 to 14), when screening and diagnostic mammograms fell by 99% and 74%, respectively. Volumes began to rebound in week 19 (May), with diagnostic mammograms reaching levels to similar to previous years’ and screening mammograms remaining 14% below expectations. We estimate it will take a minimum of 22 weeks to clear the queue of missed mammograms in our study sample.Conclusions: The provision of mammograms has been significantly disrupted due to the COVID‐19 pandemic.


  • Open Access

    Strategic Pricing and Competitive Procurement in the Physician Services Market

    by Guy Arie, Alon Bergman, Gerard J. Wedig

    We propose and test a model of the strategic interaction between public (e.g., Medicare) and private insurers in the physician services market. Our model nests